- Home
- Knowledge Base
- targeted-toxins
targeted-toxins
Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma
Guo Y, Hu J, Wang Y, Peng X, Min J, Wang J, Matthaiou E, Cheng Y, Sun K, Tong X, Fan Y, Zhang PJ, Kandalaft LE, Irving M, Coukos G, Li C (2018) Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma. Eur J Cancer 90:111-121. doi: 10.1016/j.ejca.2017.10.035. PMID: 29304474
Objective: Using Saporin conjugated to 78Fc, an antibody fragment directed towards endosialin a.k.a. CD248, in the treatment of human sarcomas.
Summary: Endosialin/CD248 is over-expressed in human sarcomas, and a human single-chain variable fragment -Fc fusion protein was created targeting CD248. 78Fc-SAP eliminated CD248+ cells without off-target toxicity in vivo in mice and in vitro in human sarcoma cells.
Usage: In vivo: Mice were inoculated with osteosarcoma cells. These mice received, in PBS, either 4 ug of 78Fc-SAP, 1.4 ug of free saporin [PR-01], or no drug. In vitro: At 2.2 nM nearly 100% of CD248+ human sarcoma cell lines ( SJSA-1, A673, MES-SA and HOS) were eliminated. At the same concentration with free saporin ~20% of cells were eliminated.
Related Products: Saporin (Cat. #PR-01)
5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin
Lund K, Olsen CE, Wong JJW, Olsen PA, Solberg NT, Høgset A, Krauss S, Selbo PK (2017) 5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin. J Exp Clin Cancer Res 36(1):185.. doi: 10.1186/s13046-017-0662-6
Objective: Investigate resistance mechanisms and photochemical strategies to overcome 5-FU resistance in pancreatic adenocarcinoma.
Summary: Expression of CD105 was investigated using RT-qPCR, western blotting, flow cytometry, and fluorescence microscopy, and co-localization of TPCS2a and Anti-CD105-SAP was assessed using microscopy. MTS assay was used to investigate cytotoxic effects of photochemical internalization of Anti-CD105-SAP. For the first time, we demonstrate the promise of PCI-based targeting of CD105 in site-specific elimination of 5-FU resistant pancreatic cancer cells using Anti-CD105-SAP in vitro. PCI-based targeting of CD105 may represent a potent anti-cancer strategy and should be further evaluated in preclinical models.
Usage: Cells were seeded (3000/well) in 96-well plates and allowed to attach overnight. The cells were incubated with the Anti-CD105-saporin (2.4 nM) or Saporin as a control (6.48 nM; Saporin was added in a molecular ratio of 2.7:1 to the immunotoxin) giving an equal ratio of Saporin to immunotoxin), with or without the photosensitizer TPCS2a (0.35 μg/ml) for 18 h.
Related Products: Anti-CD105-SAP (Cat. #IT-80)
Regulation of reentrainment function is dependent on a certain minimal number of intact functional iprgcs in rd mice
Zhang J, Wang H, Wu S, Liu Q, Wang N (2017) Regulation of reentrainment function is dependent on a certain minimal number of intact functional iprgcs in rd mice. J Ophthalmol 2017:6804853.. doi: 10.1155/2017/6804853
Related Products: Melanopsin-SAP (Cat. #IT-44)
A streamlined method for the preparation of gelatin embedded brains and simplified organization of sections for serial reconstructions
Liu A, Aoki S, Wickens J (2017) A streamlined method for the preparation of gelatin embedded brains and simplified organization of sections for serial reconstructions. Bio-protocol 7(22):e2610.. doi: 10.21769/BioProtoc.2610
Related Products: Anti-ChAT-SAP (Cat. #IT-42)
Patch compartment lesions reduce habitual sucrose consumption
Horner KA, Logue JB, Jenrette TA (2017) Patch compartment lesions reduce habitual sucrose consumption. Neuroscience 2017 Abstracts 689.16 / II23. Society for Neuroscience, Washington, DC.
Summary: The striatum mediates habit formation and reward association. The striatum can be divided into the patch and matrix compartment, which are two neurochemically and anatomically distinct regions that may sub-serve different aspects of behavior. For example, the patch compartment may mediate reward-related behaviors, while the matrix compartment may mediate adaptive motor functions. Furthermore, previous studies have shown that enhanced relative activation of the patch versus matrix compartment is associated with inflexible behaviors, such as stereotypy. Habitual behaviors are also inflexible in nature, but whether enhanced activation of the patch compartment contributes to habitual behavior is not known. The goal of the current study was to examine the role of patch compartment neurons in the development of habit formation. We used dermorphin-saporin to specifically ablate neurons of the patch compartment prior to training animals to self-administer sucrose on a random interval schedule of reinforcement, which has been shown to foster habit formation. Our data showed that destruction of the neurons of the patch compartment prevented the reinstatement of sucrose self-administration after sucrose devaluation, indicating that absence of the patch compartment interrupted the development of habitual behavior. Our data also indicate that c-Fos levels were decreased in the dorsolateral striatum (DLS) and sensorimotor cortex (SMC), but increased in dorsomedial striatum (DMS) and prefrontal cortex (PFC) in patch-lesioned animals that did not develop habitual behavior, indicating that diminished habit formation is associated with decreased activation of regions that participate in habitual behavior, and increased in regions associated with goal-directed behaviors. Together, these data indicate that the patch compartment participates in habit formation by altering the flow of information through basal ganglia circuits.
Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)
Role of orexinergic neurons in the chemosensory control of breathing in a Parkinson’s disease model
Falquetto B, Oliveira LM, Moreira TS, Takakura AC (2017) Role of orexinergic neurons in the chemosensory control of breathing in a Parkinson’s disease model. Neuroscience 2017 Abstracts 779.08 / HH1. Society for Neuroscience, Washington, DC.
Summary: Parkinson´s disease (PD) is a neurodegenerative disorder characterized by progressive loss of dopaminergic neurons in the substantia nigra compacta (SNpc). Non-motor symptoms such as neuropsychiatric, sleep and breathing disorders are also observed in PD. Previous study has already demonstrated that in 6-hydroxydopamine (6-OHDA)-model of PD there is a reduction in the number of phox2b neurons in the retrotrapezoid nucleus (RTN) and a decrease in the respiratory response to hypercapnia. Here, we tested the involvement of orexin cells from lateral hypothalamus/perifornical area (LH/PeF) on breathing in this model of PD. 6-OHDA (24 µg/µl) injections into the striatum reduced the number of catecholaminergic (40 days: 128 ± 10 and 60 days: 116 ± 13 vs. vehicle: 938 ± 15 neurons) and orexin-B-ir neurons (40 days: 310 ± 9 and 60 days: 258 ± 15 vs. vehicle: 412 ± 13 neurons). The injection of anti-Orexin-B saporin into the LH/PeF produces a further reduction in the number of orexinergic neurons in PD animals (79 ± 8 vs. control: 427 ± 14 neurons). The respiratory frequency (fR) at rest and in response to hypercapnia (7% CO2) was assessed 60 days after bilateral 6-OHDA or vehicle injections into the striatum and anti-Orexin-B saporin or IgG saporin into the LH/PeF during sleep and wakefulness in the dark and light phases of the diurnal cycle. Sixty days after 6-OHDA, we observed a reduction of fR at rest during sleep in the light phase only in PD animals (56 ± 2 vs. control: 66 ± 2 bpm). During the dark phase, there is a reduction in fR response to hypercapnia in PD animals with depletion of orexinergic neurons during wakefulness (119 ± 6 vs. control: 152 ± 3 bpm) and sleep (128 ± 7 vs. control: 147 ± 5 bpm). Our data suggest that orexinergic neurons are important to restore chemoreceptor function in a rat model of PD during sleep and wakefulness in rats.
Related Products: Orexin-B-SAP (Cat. #IT-20)
Gastrointestinal vagal afferent signaling promotes hippocampal-dependent memory function in rats
Suarez AN, Hsu TM, DeLartigue G, Kanoski SE (2017) Gastrointestinal vagal afferent signaling promotes hippocampal-dependent memory function in rats. Neuroscience 2017 Abstracts 510.22 / PP13. Society for Neuroscience, Washington, DC.
Summary: The vagus nerve is the primary conduit of communication between feeding-relevant gastrointestinal (GI) signals and the brain. Vagally-mediated GI satiation signals, including gastric distension and intra-gastric nutrient infusion, activate neurons in the hippocampus (HPC) through unidentified polysynaptic pathways. The functional relevance of GI-derived communication to the HPC is unknown. Here we first explored whether chronic disruption of gut-to-brain vagal tone via subdiaphragmatic vagotomy (SDV) negatively impacts HPC-dependent memory function in rats. While SDV did not impair HPC-dependent appetitive learning based on interoceptive energy status cues or social food-related cues, SDV did impair spatial working memory (Barnes maze) and contextual episodic memory (novel object in context; NOIC), two HPC-dependent tasks that involve processing of visuospatial stimuli. Next, to determine whether vagal sensory/afferent vs. motor/efferent signaling regulates HPC-dependent memory function, we employed a novel approach in which a saporin conjugated to cholecystokinin (CCK-SAP) or an unconjugated control saporin is injected into the nodose ganglia, a strategy that preserves 100% of vagal efferent signaling while eliminating ~80% of GI-derived vagal afferent signaling. Similar to SDV rats, CCK-SAP rats were impaired in both the Barne’s maze task and NOIC learning relative to controls. Consistent with the memory deficits, immunoblot protein analyses in hippocampus lysates revealed reduced neurotophic [brain- derived neurotrophic factor (BDNF)], and neurogenesis [doublecortin (DCX)] markers in both SDV and CCK-SAP rats relative to controls. These findings indicate that GI-derived vagal afferent signaling is critical in regulating HPC-dependent mnemonic function. Results have direct clinical relevance, as procedures that chronically disrupt vagus nerve signaling (e.g., vBloc) have recently been FDA-approved for obesity treatment.
Related Products: CCK-SAP (Cat. #IT-31)
RVLM C1 neuron ablation normalizes cardiorespiratory control in heart failure
Del Rio R, Andrade DC, Toledo C, Diaz HS (2017) RVLM C1 neuron ablation normalizes cardiorespiratory control in heart failure. Neuroscience 2017 Abstracts 507.13 / NN21. Society for Neuroscience, Washington, DC.
Summary: Heart failure (CHF) is characterized by sympathoexcitation and breathing disorders. The rostral ventrolateral medulla (RVLM) is hyperactive in CHF. However, there is no direct evidence between the relationship of RVLM chronic hyperactivation, sympathoexcitation and progression of cardiac deterioration in CHF. We hypothesized that selective elimination of cathecolaminergic neurons from the RVLM delays cardiac deterioration in CHF rats. CHF was induced by volume overload in male Sprague-Dawley rats (250±20g). Ablation of C1 cells was performed by anti-dopamine-beta hydroxylase (DβH)–saporin toxin (DβH+SAP) injected into the RVLM. The degree of HF was estimated by echocardiography. Cardiac function was assessed by intraventricular PV loops. Arrhythmia index and breathing disorders were scored. Central and peripheral chemoreflex and cardiac autonomic control were also study. Partial elimination of C1 RVLM neurons (≈50%) delay the decrease in fractional shortening in CHF rats (CHF+Veh: 59±5 vs. 45±1 %, p<0.05, pre vs. post vehicle, respectively; CHF+DβH-SAP: 57±4 vs. 51±4 %, p>0.05, pre vs. post toxin, respectively). In addition, compared to CHF vehicle treated rats, CHF+DβH-SAP rats showed (CHF+Veh vs. CHF+DβH-SAP, respectively): i) a reduced cardiac sympathetic drive (-98±12 vs. -52±7 ΔHR, p<0.05), ii) an improvement in both cardiac diastolic (0.009±0.001 vs. 0.004±0.001 mmHg/µl, p<0.05) and systolic function (0.2±0.01 vs. 0.5±0.1 mmHg/µl, p<0.05), iii) a reduced number of arrhythmias (95±20 vs. 48±14 events/hour, p<0.05), and iv) a reduced incidence of breathing disorders (9±1 vs. 6±1 apneas/hour, p<0.05). Finally, the detrimental autonomic and cardiovascular effects induced by central chemoreceptors activation were abolished after C1 neurons ablation in CHF rats. Neither hypoxic nor hypercapnic ventilatory chemoreflex responses were affected by DβH- SAP treatment. Our results showed that the RVLM play a pivotal role on the progression of cardiac deterioration and in the maintenance of autonomic imbalance and breathing disorders in CHF. In addition, our results showed that the sympathoexcitation and cardiac function deterioration induced by central chemoreflex activation is related to the activation of RVLM C1 neurons.
Related Products: Anti-DBH-SAP (Cat. #IT-03)
Distinct roles of NMB and GRP in itch transmission.
Wan L, Jin H, Liu X, Jeffry J, Barry D, Shen K, Peng J, Liu X, Jin J, Sun Y, Kim R, Meng Q, Mo P, Yin J, Tao A, Bardoni R, Chen Z (2017) Distinct roles of NMB and GRP in itch transmission. Sci Rep 7:15466.. doi: 10.1038/s41598-017-15756-0
Summary: To examine the role of NMBR+ dorsal horn neurons in itch and pain transmission, the authors treated mice with NMB-SAP (Cat. #IT-70; 2–3 μg, i.t.) at which no side effects were observed. NMB-SAP treated mice barely showed scratching behaviors, whereas control mice exhibited NMB-induced scratching with a rapid onset of scratching responses. These data demonstrate an important role of NMBR+ neurons in itch transmission. In contrast to notable deficits in itch transmission, NMB-SAP treated mice exhibited normal behavioral responses to acute mechanical stimuli, thermal stimuli and tail immersion. The authors also examined inflammatory pain behaviors of NMB-SAP treated mice and found normal nocifensive behaviors.
Related Products: NMB-SAP (Cat. #IT-70)
Vagus nerve stimulation dependent enhancement of motor cortex plasticity requires noradrenergic innervation
Hulsey D, Shedd M, Mong J, Rennaker RL, Hays SA, Kilgard MP (2017) Vagus nerve stimulation dependent enhancement of motor cortex plasticity requires noradrenergic innervation. Neuroscience 2017 Abstracts 317.06 / HH5. Society for Neuroscience, Washington, DC.
Summary: Pairing forelimb movements with vagus nerve stimulation (VNS) drives robust plasticity within primary motor cortex (M1). VNS activates cholinergic circuits, which are required for VNS-depended enhancement of plasticity. However, there may be multiple neuromodulatory mechanisms required for VNS-dependent enhancement of plasticity. Norepinephrine regulates plasticity, and the noradrenergic locus coeruleus is driven vigorously by VNS. However, the role of norepinephrine in VNS-dependent enhancement of plasticity is unknown. We hypothesize that noradrenergic innervation of M1 and/or basal forebrain is necessary for M1 plasticity associated with VNS pairing. To test this, we trained rats on a skilled lever press task emphasizing use of the proximal forelimb. After demonstrating proficiency on the task, rats received M1 injections of vehicle or DBH-Saporin to selectively deplete norepinephrine in motor cortex, and underwent implantation of a stimulating cuff electrode on the vagus nerve. Sham and NE- lesioned rats resumed training one week after surgery. After returning to pre-surgical performance, both groups received 10 sessions of training with VNS paired on successful trials. Intracortical microstimulation was performed to derive M1 maps within 24 hours of the final training session. Initial data suggests that sham lesioned animals who receive VNS pairing with successful trials show a robust expansion of proximal forelimb movements represented in M1. Noradrenergic lesion of M1 blocks this VNS- dependent expansion of proximal forelimb representation, indicating that cortical norepinephrine innervation is necessary for VNS driven plasticity. Ongoing experiments will determine whether noradrenergic input to the central cholinergic systems is required for VNS-dependent enhancement of plasticity.
Related Products: Anti-DBH-SAP (Cat. #IT-03)
